Poplar POINT Capital Partners L.P., 10% Owner at NovaBay Pharmaceuticals, Inc. (NBY), bought 123,365 shares at $0.59 ($75K) on 2025-03-31, disclosed to the SEC on 2025-04-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.61 | 13,292 | $8K | 10.9% |
| 2 | $0.61 | 600 | $366 | 0.5% |
| 3 | $0.62 | 18,504 | $11K | 15.4% |
| 4 | $0.61 | 49,400 | $30K | 40.4% |
| 5 | $0.59 | 21,654 | $13K | 17.1% |
| 6 | $0.59 | 19,915 |
| $12K |
| 15.7% |
| Total | $0.60 avg | 123,365 | $75K | 100% |
| Filing → |
| EMRI | BUY | 2015-07-02 | $183K | — | Filing → |
| SCMR | BUY | 2014-11-13 | $338K | — | Filing → |